GO:0070335 aspartate binding: Mechanism, Genes and Research Methods

Aspartate binding (GO:0070335) is a molecular function that describes the selective interaction of a protein or biomolecule with aspartate, the alpha-amino-acid anion of 2-aminobutanedioic acid (C4H5NO4). This function is fundamental to many biological processes, including excitatory amino acid neurotransmission, cellular nitrogen metabolism, and secondary-active transport across membranes. Early radioreceptor binding studies established that specific, saturable binding sites for L-aspartate exist in brain tissue, distinguishing them from glutamate binding sites and implicating aspartate in excitatory signaling. Beyond neurotransmission, aspartate binding is a key step in the catalytic cycles of sodium-coupled transporters. For example, the glutamate transporter homologue GltPh from Pyrococcus horikoshii binds aspartate with high affinity only after sodium ions have bound, revealing a coupled binding mechanism that ensures substrate capture is energetically favorable. Similarly, the GltTk transporter from Thermococcus kodakarensis couples the binding of three sodium ions and aspartate in a sequential manner. These findings illustrate how aspartate binding is not a simple bimolecular event but is often regulated by ion gradients and conformational states. In bacteria, the aspartate receptor Tar mediates chemotaxis by binding aspartate in its periplasmic ligand-binding domain, triggering a transmembrane signal. The modulation of aspartate binding by divalent cations such as calcium and by temperature further highlights the physicochemical complexity of this interaction. For researchers, GO:0070335 provides a precise annotation for proteins that directly and selectively bind aspartate, enabling functional genomics, structural studies, and drug discovery efforts targeting excitatory amino acid systems.

GO:0070335 (aspartate binding) is defined by QuickGO as the binding to aspartate, the alpha-amino-acid anion of 2-aminobutanedioic acid that has formula C4H5NO4. In practical terms, it is a molecular function annotation assigned to gene products that physically interact with aspartate via non-covalent forces, including hydrogen bonding, electrostatic interactions, and hydrophobic contacts. The synonym aspartic acid binding is also used. This term does not describe catalysis or transport per se, but rather the selective recognition and reversible association with the aspartate molecule.

Aspartate binding is important because aspartate is a key excitatory amino acid and a central metabolite. Proteins that bind aspartate control synaptic signaling, nitrogen shuttling, and ion-coupled transport. Dysregulation of aspartate binding sites has been linked to neurological and metabolic disorders, and the mechanism of coupled ion-substrate binding informs the design of inhibitors and therapeutics.

The following genes and proteins are representative of aspartate binding function, based on published biochemical and structural studies.

Aspartate binding can be regulated at multiple levels. In transporters, the binding affinity for aspartate is allosterically coupled to sodium ion occupancy, as shown for GltPh and GltTk. Calcium ions and temperature can modulate aspartate binding directly. At the cellular level, expression levels of aspartate-binding proteins are controlled by transcription factors and signaling pathways, although specific regulators vary by cell type. Post-translational modifications such as phosphorylation may also affect binding activity, but detailed mechanisms remain to be fully elucidated for many proteins.

Aspartate is an excitatory amino acid, and dysregulated aspartate binding to receptors or transporters can contribute to excitotoxicity. Radioreceptor binding studies have mapped aspartate binding sites in the brain, linking them to excitatory neurotransmission. Alterations in these sites may be involved in conditions such as epilepsy, ischemia, and neurodegenerative diseases, although direct causal evidence in humans is still limited.

Aspartate binding is essential for enzymes in the urea cycle and pyrimidine synthesis. Deficiencies in enzymes such as argininosuccinate synthase (ASS1) or argininosuccinate lyase (ASL) lead to metabolic disorders including citrullinemia and argininosuccinic aciduria. These enzymes bind aspartate as a substrate, and mutations affecting aspartate binding can impair their function.

Aspartate is a key metabolite in cancer cells, supporting nucleotide synthesis and redox balance. Proteins that bind and transport aspartate, such as mitochondrial carriers, are being investigated as potential targets in cancer. However, specific links between aspartate binding function and cancer remain an active area of research.

Radioreceptor binding studies using tritiated aspartate have been used to identify and characterize aspartate binding sites in brain membranes. These assays measure affinity, density, and pharmacology of binding sites and can be adapted to cell lines.

Stopped-flow kinetics and X-ray crystallography have revealed the ordered binding of sodium ions and aspartate in GltPh and GltTk. Structural analysis of the Tar ligand-binding domain has provided snapshots of aspartate recognition.

Autoradiography with L-[3H]aspartate has been used to map the distribution of aspartate binding sites in tissue sections, providing spatial information about excitatory amino acid systems.

CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of specific aspartate-binding proteins in cellular processes. These approaches can be combined with biochemical binding assays to link genotype to function.

Researchers studying aspartate binding-related genes often need to determine whether a candidate gene is causally involved in a specific biological process. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation of aspartate-binding proteins.

Aspartate binding (GO:0070335) is a fundamental molecular function that underpins excitatory neurotransmission, ion-coupled transport, and key metabolic pathways. Decades of research have revealed the structural and kinetic mechanisms of aspartate recognition, from bacterial receptors to human transporters. Understanding these mechanisms provides insights into neurological and metabolic diseases and offers opportunities for therapeutic intervention. With advanced CRISPR tools, researchers can now precisely perturb aspartate-binding proteins to uncover their roles in health and disease.